A novel therapeutic agent for heart failure, atrial fibrillation and chronic kidney disease, ryanodine receptor 2 inhibitor, M201-A
Company Philosophy
Business Strategy
Development Products
News Release
Company Profile
Recruitment
Licensing/Contact Us
Menu
Home/Recruitment